Reply by Authors

J Urol. 2023 Feb;209(2):362-363. doi: 10.1097/JU.0000000000003038.02. Epub 2023 Feb 1.

Michael T Schweizer^{1

2}, Lawrence True³, Roman Gulati⁴, Yibai Zhao⁴, William Ellis⁵, George Schade⁵, Bruce Montgomery^{1

2

6}, Sonia Goyal¹, Katie Nega¹, Alexander K Hakansson⁷, Yang Liu⁷, Elai Davicioni⁷, Kenneth Pienta⁸, Peter S Nelson^{1

2

9}, Daniel Lin⁵, Jonathan Wright⁵

¹ Department of Medicine, University of Washington, Seattle, Washington.
² Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
³ Department of Pathology, University of Washington, Seattle, Washington.
⁴ Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
⁵ Department of Urology, University of Washington, Seattle, Washington.
⁶ VA Puget Sound Health Care System and Prostate Cancer Foundation POPCAP Network, Seattle, Washington.
⁷ Veracyte, Inc., San Francisco, California.
⁸ The James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, Maryland.
⁹ Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington.

No abstract available

Publication types